ICM
ICM is a gene therapy developer company for incurable diseases.
ICM
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2012-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.icm-bio.com
Status:
Active
Contact:
82-2-324-8560
Email Addresses:
[email protected]
Technology used in webpage:
Euro Google Apps For Business ASP.NET IIS Pound Sterling IIS 10 Japanese Yen Classic ASP SK Broadband
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Official Site Inspections
http://www.icm-bio.com
- Host name: 58.230.162.200
- IP address: 58.230.162.200
- Location: Daegu South Korea
- Latitude: 35.8723
- Longitude: 128.5924
- Timezone: Asia/Seoul
- Postal: 41934
More informations about "ICM"
์์ด์จ์ ์ฃผ์ํ์ฌ ICM Co.,Ltd.
ICM was established in 2012 as a subsidiary of Yonsei Technology Holdings. View More. Gene Therapy. Offers the prospect of disease modifying treatment by delivering therapeutic gene to target tissues. AAV Gene Therapy. OASys; โฆSee details»
์์ด์จ์ ์ฃผ์ํ์ฌ ICM Co.,Ltd.
Company Overview. ์์ด์จ์ ์ฃผ์ํ์ฌ๋ 2012๋ ์ฐ์ธ๋ํ๊ต ๊ธฐ์ ์ง์ฃผํ์ฌ ์ํ์ฌ๋ก ์ค๋ฆฝ๋์์ผ๋ฉฐ ํดํ์ฑ ์งํ ์น๋ฃ๋ฅผ ์ํ ์ฒจ๋จ ๋ฐ์ด์ค์์ฝํ์See details»
์์ด์จ์ ์ฃผ์ํ์ฌ ICM Co.,Ltd.
ICM aims to develop โFirst-in-Classโ gene therapies for incurable degenerative diseases. ... ICM stands for โInnovative Cure in Medicineโ. Our wordmark symbolizes โGlobeโ and โBioโ, which โฆSee details»
Home - Insurance of Manitoba
Welcome to the Insurance Council of Manitoba The Insurance Council of Manitoba is the regulatory body responsible for the licensing and regulatory compliance of insurance agents, โฆSee details»
ICM - Crunchbase Company Profile & Funding
ICM is a gene therapy developer company for incurable diseases. ... Experience the new Crunchbase, powered by AI . Organization. ICM . Connect to CRM . Save . Summary. โฆSee details»
ICM (Drug Discovery) 2025 Company Profile: Valuation, โฆ
Jan 1, 2019 Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; JP-2024168384-A: Animal collars: Pending: 23-May-2023: US-20230149506-A1: Pharmaceutical composition for treating retinal dystrophies, โฆSee details»
ICM Co. Ltd. | MedPath
Https://icm-bio.com. Clinical Trials. Related News. A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo. Conditions. Osteoarthritis, Knee. ... Subscribe. First โฆSee details»
ICM Co. Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ICM Co. Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, Disease Domain:Nervous System Diseases, Immune System Diseases, Technology โฆSee details»
Icmbio - Overview, News & Similar companies | ZoomInfo.com
Www.icm-bio.com. Revenue $9.5 Million. Industry Textiles & Apparel Consumer Goods Manufacturing . Recent News & Media. No recent news or media. Overview ; Org Chart ; Who โฆSee details»
ICM Co. Ltd. (ICM Co. Ltd.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ_ๆ โฆ
The purpose of this study is to determine the safety, tolerability, and activity of ICM-203, a recombinant adeno-associated viral (AAV) vector that expresses a therapeutic gene that โฆSee details»
Separation Technologies and Feed Products | ICM
The majority of U.S. ethanol plants use ICM separation technologies. Discover processing equipment and services for creating biofuel and feed products.See details»
About Us - ICM Inc
Plants using ICM technology collectively produce 8.8 billion gallons annually. No other brand serves more ethanol producers in the world. For over 25 years, we have been advancing the โฆSee details»
Biotech Firm KnipBio and Biofuels Leader ICM Inc. Ink Collaboration
Apr 10, 2018 About ICM, Inc: Established in 1995 and headquartered in Colwich, Kan., ICM, Inc., provides innovative technologies, solutions, and services to sustain agriculture and โฆSee details»
์์ด์จ์ ์ฃผ์ํ์ฌ ICM Co.,Ltd.
ICM pursues novel therapeutic solutions for incurable degenerative diseases. Company. Management Team. An experienced team with global competitiveness Dae-Won Kim, Ph.D. โฆSee details»
USBI-NABC24-Bennett_ICM_Feb14-Large_Scale_Biomass ... - Biochar
The basis for the ICM design was originally developed in the late 1970s and demonstrated at a feedstock input capacity of up to 240 ton/day. In 2008 ICM began collaborating with the โฆSee details»
ICM-Bio User Guide v.3.8 - molsoft.com
2.4 ICM-Chemist Reference Guide 2.5 Menu Option Guide 2.6 Tab Guide 3 Getting Started 3.1 The Basics of the Graphical User Interface 3.2 How to search and download Protein Structure, โฆSee details»
Molsoft L.L.C.: ICM-Bio
ICM Bioinformatics Features. Accurate pairwise alignments and their significance: ICM includes two high-quality global pairwise alignment algorithms with zero-end penalties (ZEGA). double โฆSee details»
BIO Statement on Resignation of Peter Marks from the FDA
1 day ago John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the โฆSee details»
์์ด์จ์ ์ฃผ์ํ์ฌ ICM Co.,Ltd.
ํ๊ตญ์ ์ ์์ธํฌ์น๋ฃํํ (Korean Society of Gene and Cell Therapy) - ํ์ฅ (2023-2024) ๋ํ์ฐ๊ณจ ๋ฐ ๊ณจ๊ด์ ์ผํํ (Korean Society of Cartilage and Osteoarthritis)See details»
์์ด์จ์ ์ฃผ์ํ์ฌ ICM Co.,Ltd.
Initiated Phase1/2a global clinical trial for ICM-203; 2020. Completion of ICM-203 GMP Production; Completion of ICM-203 GLP Tox/BD Study; License-out agreement of ICM-203 โฆSee details»